If you enjoy this content, please share it with a colleague
RELATED CONTENT
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first group of prostate cancer patients treated at the center after it opened in March 2012. At the time, it was the 10th proton therapy treatment center in the United States, welcoming patients with various cancer types that could benefit from this advanced form of radiation treatment.
Proton therapy is becoming more prevalent in cancer treatment as it is the most advanced form of radiation available. Proton beams are more precise, treating complex tumors while avoiding healthy tissues and critical structures. Proton therapy centers are beginning to spring up around the United States as physicians continue to see the benefits in cancer treatment. One center that has garnered much attention is the CDH Proton Center in Warrenville, Ill.
Proton beam therapy, already the most advanced and precise form of therapy for the eradication of cancers, has taken a major technological leap forward with the introduction of pencil beam scanning at the ProCure Proton Therapy Center in Somerset, N.J., the only proton facility in the New York/New Jersey/Connecticut tri-state region.
Radiation therapy has played an important role in the treatment of cancer for more than a century. Used typically as a curative treatment either alone or in conjunction with surgery and/or chemotherapy, the aim of radiation therapy has always been to eradicate a patient’s cancer.
We are witnessing a new era in proton therapy research, with an unprecedented number of clinical studies under way. For three decades, research has focused heavily on pediatric tumors and tumors of the brain, spine and prostate, establishing that proton therapy is efficacious, enables precise targeting of tumors permitting higher doses of radiation with few short- and long-term side effects, and maintains a high quality of life for patients.[1-9] The treatment also has been shown to reduce the likelihood of treatment-related malignancies.[10] Researchers now are exploring the clinically meaningful benefit of proton therapy in diseases of high incidence, particularly lung and breast cancer, where the precision and limited side effects can provide effective treatment with significant long-term benefit to the patient. Initial results prove hopeful, especially for lung cancer, which remains the No. 1 cancer killer of both men and women.[11]
The Remote Mobile Anesthesia System, initially developed for use in proton treatment centers but useful in any medical setting, provides the ability to administer anesthesia to a patient before, during and after proton therapy treatment without interruption, reducing preparation and treatment time by as much as 30 percent.
The Warrenville, Ill.-based CDH Proton Center, A ProCure Center, announced the installation of pencil beam scanning, which delivers a more precise dose of proton therapy to further minimize exposure of healthy tissue to radiation and allow radiation oncologists to better treat more complex tumors.
An innovative modification of a treatment chair used with cancer patients allows those who have problems lying down during procedures to sit upright, providing greater comfort. The modified chair was developed to be used for proton therapy but can also be used in conventional radiation therapy, providing the chair can be attached to a robotic positioner.
For men undergoing proton therapy for prostate cancer, fewer treatments with higher doses appear to be well tolerated, according to early clinical trial results. The trial, which continues to enroll patients, is evaluating using only 5 proton treatments given over 2 weeks for patients with low risk prostate cancer, a fraction of the 44 treatments typical in an 8-week standard course of therapy.
March 10, 2011 – The CDH Proton Center in suburban Chicago can now treat a wider variety of cancer tumors with the opening of a new treatment room. The room features a gantry, a nearly 100-ton rotating steel wheel that allows the proton beam to be directed at the tumor from any angle.